During the past decade, Oregon Medical Research Center conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 43 clinical trials were completed, i.e. on average, 97.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 26 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Medical Research Center" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Pfizer" with 8 trials sponsored, "Galderma R&D" with 5 trials sponsored, "Incyte Corporation" with 4 trials sponsored and "Peplin" with 4 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Medical Research Center" #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Accenture" with 1 trials as a collaborator and "Athenex, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Medical Research Center" are "Psoriasis" (17 trials), "Atopic Dermatitis" (11 trials), "Actinic Keratosis" (8 trials), "Plaque Psoriasis" (8 trials) and "Onychomycosis" (6 trials). Many other conditions were trialed in "Oregon Medical Research Center" in a lesser frequency.

Most popular intervention types in "Oregon Medical Research Center" are "Drug" (82 trials), "Other" (12 trials), "Biological" (7 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Vehicle" (7 trials), "Lebrikizumab" (6 trials), "Apremilast" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Medical Research Center" are 85 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Oregon Medical Research Center". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 70 completed trials in Oregon Medical Research Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Medical Research Center, 2 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".